Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-119-5 | CAS number: 1303-36-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2400 (Acute Eye Irritation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Diarsenic triselenide
- EC Number:
- 215-119-5
- EC Name:
- Diarsenic triselenide
- Cas Number:
- 1303-36-2
- Molecular formula:
- As2Se3
- IUPAC Name:
- diarsenic triselenide
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: E15-01025
- Expiration date of the lot/batch: 31 Jan 2035
- Purity test date: Jan 2015
OTHER SPECIFICS:
- Appearance: black solid
- Purity: 100%
- Storage conditions: controlled room temperature (15-25°C, <70 RH%)
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: S&K LAP Kft, 2173 kartal, Csaszar ut 135, Hungary
- Age at study initiation: 13-14 weeks old
- Sex: Male
- Weight at study initiation: 3366-3728g
- Housing: individually housed in AAALAC approved metal wire rabbit cages of an open wire structure and placed together to allow some social interaction with rabbit(s) in adjoining cages.
- Diet (e.g. ad libitum): ad libitum UNI diet for rabbits, produced by Cargill Takarmany Zrt, 5300 Karcag, Madarasi ut 0399, Hungary.
- Water (e.g. ad libitum): ad libitum municipal tap water from an automatic system
- Acclimation period: at least 26 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19,0 - 24,1 °C
- Humidity (%):36-79%
- Air changes (per hr): 15-20 air exchanges/hour
- Photoperiod (hrs dark / hrs light): 12h light, from 6.00 am to 6.00 pm
Test system
- Controls:
- yes
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 1 single dose of 0.1g test item
VEHICLE
- Amount(s) applied (volume or weight with unit):
- Concentration (if solution):
- Lot/batch no. (if required):
- Purity: - Duration of treatment / exposure:
- 72 hours
- Observation period (in vivo):
- 1, 24, 48, 72 hours
- Number of animals or in vitro replicates:
- 3
- Details on study design:
- - test item was placed into the conjunctival sac of the left eye.
- pH was assessed by measurement of the supernatant from a 1ù w/v mixture in distilled water according to CIPAC MT75. pH was found to be 5.0 (and permitted for use in animal studies).
OTHER MATERIALS USED
- For washing: disposable syringe luer solo 20 ml, NaCl 0.9%
- Systemic opiate analgesic: Bupaq 0.3 mg/ml
- Topical ocular anaesthetic: Humacain 4 mg/ml
- Nonsteroidal anti-inflammatory drug: Metacam 5 mg/ml
- Euthanasia: Ketamidor, Primazin 2%, Euthanimal 40% (pentabarbital sodium)
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- other: conjunctival redness
- Basis:
- animal: 1, 2 and 3
- Time point:
- other: 1 hour
- Score:
- 2
- Max. score:
- 3
- Reversibility:
- fully reversible within: 48h
- Irritation parameter:
- chemosis score
- Basis:
- animal: 1, 2 and 3
- Time point:
- other: 1 hour
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 24h
- Irritation parameter:
- other: conjunctival redness
- Basis:
- animal: 1, 2 and 3
- Time point:
- 24 h
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 48h
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item GASIR5, applied to rabbit eye mucosa, caused conjunctival effects at 1 hour after application which were fully reversible within 48 hours.
According to Regulation EC 1272/2008, GASITR5 does not require classification as an eye irritant. - Executive summary:
An acute eye irritation study of the test item GASIR5 was performed in New Zealand White rabbits. The irritation effects of the test item were evaluated according to the Draize method (OECD No.: 405, 2012). Rabbits were treated with analgesic and anaesthetic as per the regulatory guideline. Three animals were used to make the classification.
The test item was placed into the conjunctival sac of the left eye of each animal. The untreated right eye served as control. A single amount of 0.1 g of the test item was administered as a single dose.
The eyes were examined at 1, 24, 48 and 72 hours after application.
No Initial Pain Reaction(IPR) or any Pain Reaction (PR) was observed during the experimental period.
Animal 1 (No: 405) clinical observation
At one hour after the application, conjunctival redness (score 2), chemosis (score 1) and discharge (score 2) were noted in the rabbit. Test item remained in the eye sac.
At 24 hour after the application,conjunctival redness (score 1) was observed in the rabbit.At 48 and 72 hours after the application,no clinical signs, and no conjunctival or corneal effects were observed.
Animal 2 (No: 421) clinical observation
At one hour after the application, conjunctival redness (score 2), chemosis (score 1) and discharge (score 1) were noted in the rabbit. Test item remained in the eye sac.
At 24 hour after the application,conjunctival redness (score 1) was observed in the rabbit.At 48 and 72 hours after the application,no clinical signs, and no conjunctival or corneal effects were observed.
Animal 3 (No: 397) clinical observation
At one hour after the application, conjunctival redness (score 2), chemosis (score 1) and discharge (score 1) were noted in the rabbit. Test item remained in the eye sac.
At 24 hour after the application,conjunctival redness (score 1) was observed in the rabbit.At 48 and 72 hours after the application,no clinical signs, and no conjunctival or corneal effects were observed.
In all animals the fur around the treated eye was coloured black by the test item at 1, 24, 48 and 72 hours after the application.
As no clinical signs were observed, the experiment was terminated after 72 hours observation. During the experiment, the control eye of each animal was symptom-free.
The general state and behaviour of animals were normal throughout the study period.
No mortality occurred during the study. The bodyweights of all rabbits were considered to be within the normal range of variability.The animals’ individual mean scores (considering readings at 24, 48 and 72 hours after the treatment) were as follows:
Chemosis Discharge Redness Cornea Iris
Animal 1 0.00 0.00 0.33 0.00 0.00
Animal 2 0.00 0.00 0.33 0.00 0.00
Animal 3 0.00 0.00 0.33 0.00 0.00
The test item GASIR5, applied to rabbit eye mucosa, caused conjunctival effects at one hour after application which were fully reversible within 48 hours.
According to Regulation (EC) No 1272/2008, GASIR5 does not require classification as an eye irritant.
According to the UN Globally Harmonised System of Classification and Labelling of Chemicals, GASIR5 does not require classification as an eye irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.